Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00520962|
Recruitment Status : Completed
First Posted : August 27, 2007
Last Update Posted : August 27, 2007
The study aims to evaluate IFG, IGT or unknown type 2 diabetes mellitus in new classes at high risk to develop alterations of glucose metabolism and definition of new pathogenic mechanisms of insulin resistance and atherosclerosis.
The following classes of subjects at high risk will be considered:First degree relatives of patients with type 2 diabetes mellitus, patients with cardiovascular disease and stroke, patients with heart valve disease. age will be > 30 years, both gender.
|Condition or disease|
|Diabetes Mellitus, Type 2|
|Study Type :||Observational|
|Actual Enrollment :||1997 participants|
|Observational Model:||Defined Population|
|Official Title:||New Physiopathogenics Mechanisms Susceptible of Pharmacological Developments (Insulin Resistance and Atherosclerosis)|
|Study Start Date :||June 1997|
|Actual Study Completion Date :||May 2006|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00520962
|Medicine Division, Diabetology, Endocrinology and Metabolic Disease Unit, IRCCS San Raffaele|
|Milan, Italy, 20132|
|Principal Investigator:||PierMarco Piatti, MD||IRCSS San Raffaele|